Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

By P. Nahid, Susan E. Dorman, N. Alipanah, Pennan M. Barry, Jan L. Brozek, A. Cattamanchi, L. H. Chaisson, R. E. Chaisson, Charles L. Daley, M. Grzemska and 17 more. Clinical Infectious Diseases, 2016

1,212 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases, Surgery

View Paper: https://www.semanticscholar.org/paper/798f2b6357a4f317e317027409492b9340b2fffb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. T. Marras
2. Richard J. Wallace

In Infectious Diseases

1. T. Marras
2. Richard J. Wallace

Citations in the corpus

• Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline (2020, background): “Experts would consider performing TDM in situations in which drug malabsorption, drug underdosing, or clinically important drug-drug interactions are suspected [227].”